较低的加多剂量对脑膜瘤的核磁共振成像进行比较评估:我们可以走多低?
Tshea Dowers1, Ali Helmi1, Achire N Mbanwi1
1From the Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
AJNR. American journal of neuroradiology
|June 10, 2024
概括
将阴道瘤MRI的加多剂量降低到62%可以保持诊断质量. 低于这个水平的剂量显著损害瘤分化,使其不适合临床使用.
科学领域:
- 神经辐射学神经辐射学
- 瘤成像学成像学
- 医学成像对比剂 医学成像对比剂 对比剂
背景情况:
- 基于加多的对比剂 (GBCA) 是用于脑膜瘤成像的标准.
- 由于对GBCA副作用,成本和环境影响的担忧,需要采取剂量减少策略.
- 脑膜瘤通常在标准剂量时表现出强烈的增强,这表明可能需要更低剂量.
研究的目的:
- 评估降低加多剂量对区分脑膜瘤与相邻的内组织的影响.
- 为了确定足够的脑膜瘤可视化所需的最小有效的加多剂量.
- 为了评估降剂量降低在脑膜瘤的可行性.MRI.
主要方法:
- 108名患有脑膜瘤的患者接受了脑部MRI,使用不同的加多剂量 (微:~25%,低:~62%,标准).
- 用了定性视觉评估和定量信号差异计算来区分瘤与组织.
- 统计分析包括ANOVA,麦克纳马测试和非劣等性测试.
主要成果:
- 较低的加多剂量 (低和微) 显著降低了脑膜瘤和脑组织之间的信号差异 (P < .02).
- 低剂量 (62%) 对视觉差异化标准剂量没有劣势.
- 微剂量 (25%) 导致从皮层 (P=.041) 和鼻 (P<.001) 显著更高的亚最佳分化率.
结论:
- 低于标准水平的62%的加多剂量足以充分划分脑膜瘤.
- 将剂量进一步降低至25%会损害瘤的可见性,因此不建议.
- 低剂量的GBCA可能为脑膜瘤成像提供一个可行的替代方案,平衡有效性和安全性.
相关概念视频
Imaging Studies I: CT and MRI
229
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
229
Magnetic Resonance Imaging
5.1K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.1K


